Ventosol 100ml Suspension

Salbutamol 2mg / 5 ml

COMPOSITION

Each 5 ml Contains Salbutamol Sulphate BP 2.4 mg equivalent to Salbutamol BP 2 mg: Mebendazole USP 100 mg

PHARMACOLOGY

Salbutamol is a synthetic sympathomimetic agent with predominant beta-2 adrenergic activity. Salbutamol produces bronchodilatation through stimulation of beta-2-adrenergic receptors in bronchial smooth muscles, thereby causing relaxation of bronchial muscle fibers. This action is manifested by an improvement in pulmonary function as demonstrated by spirometric measurements.

INDICATION

Ventosol (Salbutamol) is indicated as a bronchodilator for use in-

  • Asthma
  • Chronic Bronchitis
  • Emphysema and
  • Other conditions associated with airways obstruction.
DOSAGE AND ADMINISTRATION

Salbutamol tablet or syrup-

Children:

  • 2-6 years: 2.5 ml syrup, 3-4 times daily
  • 6-12 years: 5 ml syrup, 3-4 times daily
  • Over 12 years: 5-10 ml syrup, 3-4 times daily (2-4 mg tablet, 3-4 times daily)
  • Adults: 2-4 mg tablet, 3-4 times daily. Maximum single dose is 8 mg tablet.
PRECAUTION

Salbutamol should be used with caution in patients with hyperthyroidism, cardiovascular disease, occlusive vascular disorders, hypertension and aneurysms. Hypokalaemia associated with high doses of Salbutamol may result in increased susceptibility to digitalis-induced cardiac arrhythmia. Tachyphylaxis with resistance may occur with prolonged use of high dosage. Care is necessary when treating patients with diabetes mellitus or closed angle glaucoma, and in those receiving antihypertensive therapy.

SIDE EFFECTS

Salbutamol may cause fine tremor of skeletal muscles (particularly the hands), palpitations and muscle cramps. Tachycardia, tenseness, headaches and peripheral vasodilatation have been reported after large doses.

OVERDOSE

The symptoms with overdosage are angina, headache, nausea, vomiting, tremor etc. The preferred antidote for overdosage with Salbutamol is a cardio-selective beta-blocking agent but beta-blocking drugs should be used with caution in patients with a history of bronchospasm.

USE IN PREGNANCY AND LACTATION

The drug should be used during pregnancy only if the potential benefit justifies the potential risk of the fetus. It is not known whether this drug is excreted in human milk. Because of the potential of tumorigenecity shown for Salbutamol in some animal studies, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.

STORAGE

Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.

PACKING

Ventosol: Bottle containing 100ml Syrup.

Ventosol 100ml Suspension
Scroll to top